279 related articles for article (PubMed ID: 27268461)
1. Dissolution enhancement of tadalafil by liquisolid technique.
Lu M; Xing H; Yang T; Yu J; Yang Z; Sun Y; Ding P
Pharm Dev Technol; 2017 Feb; 22(1):77-89. PubMed ID: 27268461
[TBL] [Abstract][Full Text] [Related]
2. Effects of liquisolid formulations on dissolution of naproxen.
Tiong N; Elkordy AA
Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.
Wlodarski K; Tajber L; Sawicki W
Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987
[TBL] [Abstract][Full Text] [Related]
4. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
6. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
[TBL] [Abstract][Full Text] [Related]
7. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties.
Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone release from liquisolid formulations prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile liquid vehicles.
Elkordy AA; Tan XN; Essa EA
Eur J Pharm Biopharm; 2013 Feb; 83(2):203-23. PubMed ID: 22960707
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
[TBL] [Abstract][Full Text] [Related]
10. An investigation of physicochemical properties of piroxicam liquisolid compacts.
Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
Pharm Dev Technol; 2007; 12(3):337-43. PubMed ID: 17613897
[TBL] [Abstract][Full Text] [Related]
11. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
Khanfar M; Sheikh Salem M; Hawari R
Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
[TBL] [Abstract][Full Text] [Related]
12. Improving the wetting and dissolution of ibuprofen using solventless co-milling.
Varghese S; Ghoroi C
Int J Pharm; 2017 Nov; 533(1):145-155. PubMed ID: 28951348
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q
Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058
[TBL] [Abstract][Full Text] [Related]
14. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
[TBL] [Abstract][Full Text] [Related]
15. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA.
Wlodarski K; Sawicki W; Kozyra A; Tajber L
Eur J Pharm Biopharm; 2015 Oct; 96():237-46. PubMed ID: 26247119
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
17. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
Fahmy RH; Kassem MA
Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan.
Chella N; Narra N; Rama Rao T
J Drug Deliv; 2014; 2014():692793. PubMed ID: 25371826
[TBL] [Abstract][Full Text] [Related]
20. [Liquisolid technique for enhancement of dissolution prosperities of tanshinone II(A)].
Liu XQ; Meng QJ; Xu XL; Zhao J; Yang H; Yi H
Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4840-6. PubMed ID: 27245032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
